Results 181 to 190 of about 483,757 (312)
Upper Gastrointestinal Endoscopy in Elderly Patients: An Individualized Decision-Making Approach for Screening and Surveillance. [PDF]
Ono S +13 more
europepmc +1 more source
Body‐integrated photonic biosensors: Illuminating the path to active healthcare
Body‐integrated photonic biosensors are promising tools for active healthcare. These optical devices can be worn, implanted, or swallowed to monitor health signals continuously. This review introduces key sensing modalities, including fluorescence, colorimetry, SPR, LSPR, SERS, and light‐modulating materials.
Jiayue Gu +10 more
wiley +1 more source
Endoscopy training: Indian perspective
M. K. Goenka +3 more
doaj +1 more source
Association between preprocedural information and anxiety in patients undergoing gastrointestinal endoscopy with sedation: a prospective observational study. [PDF]
Quirós-Zamorano R +3 more
europepmc +1 more source
ABSTRACT Background Sinonasal malignancies (SNM) are rare, heterogeneous tumors with poor prognosis. There is an unmet need to improve treatment outcomes. Despite advances in imaging and molecular classification, optimal curative radiotherapy (RT) strategies remain undefined.
M. de Ridder +11 more
wiley +1 more source
Firm lesion consistency and whitish tissue exposure in gastrointestinal Langerhans cell histiocytosis. [PDF]
Wang X, Luo Q.
europepmc +1 more source
ABSTRACT Background Salivary gland carcinomas are uncommon malignancies with various histological subtypes harboring fusion genes. The EWSR1::ATF1 fusion gene, resulting from a translocation between chromosomes 12 and 22, is frequently observed in hyalinizing clear cell carcinoma (HCCC). However, the role of this fusion gene in HCCC oncogenesis remains
Yuri Hirai +13 more
wiley +1 more source
Causal Effects of Endoscopy Timing on Outcomes in Critically Ill Patients With Upper Gastrointestinal Bleeding: A Double Machine Learning Analysis. [PDF]
Lasington J +7 more
europepmc +1 more source
ABSTRACT Background Supportive care needs of patients receiving immune checkpoint inhibitors (ICIs) for head and neck squamous cell carcinoma (HNSCC) are ill‐defined. Hence, known treatment‐related adverse events (TRAEs) and health‐related quality of life (HRQoL) associated with ICI treatment for HNSCC were examined to inform future supportive care ...
N. D. O'Donnell +11 more
wiley +1 more source

